Sponsor pipeline

MTI Biotech Inc clinical trial pipeline

Get alerts when MTI Biotech Inc's trials change

1 active trials 0 recruiting 1 disease areas 2 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

What changed in the last 30 days

2026-08-25
Primary completion pushed: 2028-06-30 → 2028-12-30
Completion pushed: 2028-12-31 → 2029-06-30
NCT06432166 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients · Phase 1/2

Active trials by phase

Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT06432166 2-Hydroxybenzylamine (2-HOBA) Study in Early Alzheimer's Patients Alzheimer Disease Not Yet Recruiting 2026-08-24

Disease areas by active trials

Alzheimer's Disease (1)

Get alerts when MTI Biotech Inc's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free